P25 Single- and repeat-dose nonclinical data for PGN-EDO51 demonstrate potential for the treatment of Duchenne muscular dystrophy (DMD)

Autor: Holland, A., Lonkar, P., Sweeney, C., Gilbert, J., Svenstrup, N., Goyal, J.
Zdroj: In Neuromuscular Disorders October 2023 33 Supplement 1:S103-S103
Databáze: ScienceDirect